Repligen
RGEN
#2461
Rank
A$10.80 B
Marketcap
A$191.90
Share price
-0.21%
Change (1 day)
-25.79%
Change (1 year)
Categories

Earnings for Repligen (RGEN)

Earnings in 2025 (TTM): A$37.75 Million

According to Repligen 's latest financial reports the company's current earnings are A$0.70 Billion. In 2024 the company made an earning of -A$8.94 Million a decrease over its 2023 earnings that were of A$68.66 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Repligen from 1985 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) A$37.75 M-522.53%
2024 -A$8.94 Million-113.01%
2023 A$68.66 M-78.01%
2022 A$0.31 B33.37%
2021 A$0.23 B131.52%
2020 A$0.10 B101.31%
2019 A$50.23 M25.93%
2018 A$39.89 M105.61%
2017 A$19.4 M-11.46%
2016 A$21.91 M14.91%
2015 A$19.06 M20.26%
2014 A$15.85 M-51.49%
2013 A$32.68 M90.98%
2012 A$17.11 M
2010 A$0.24 M-103.81%
2009 -A$6.51 Million-223.84%
2008 A$5.25 M
2006 -A$3.53 Million229.64%
2005 -A$1.07 Million-89.16%
2004 -A$9.88 Million-16.86%
2003 -A$11.88 Million88.72%
2002 -A$6.3 Million-27.88%
2001 -A$8.73 Million-1.74%
2000 -A$8.88 Million85.93%
1999 -A$4.78 Million159.16%
1998 -A$1.85 Million85.71%
1997 -A$1 Million-70.83%
1996 -A$3.41 Million-72.41%
1995 -A$12.34 Million-60.63%
1994 -A$31.33 Million45.39%
1993 -A$21.55 Million39.45%
1992 -A$15.45 Million-32.3%
1991 -A$22.82 Million6.62%
1990 -A$21.41 Million1577.78%
1989 -A$1.28 Million-57.14%
1988 -A$2.98 Million-362.5%
1987 A$1.13 M-130.77%
1986 -A$3.69 Million136.36%
1985 -A$1.56 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
A$16.79 B 45,237.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
A$10.05 B 27,044.06%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
A$15.36 B 41,377.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$11.38 B 30,628.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-A$0.16 Billion-517.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
A$0.53 B 1,334.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
A$0.82 B 2,130.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
A$0.17 B 372.34%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$0.96 B 2,498.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
-A$31.46 Million-184.90%๐Ÿ‡บ๐Ÿ‡ธ USA